Title: Jin Li: Innovator in Genome Editing and Machine Learning
Introduction
Jin Li is an accomplished inventor based in the United States, known for his innovative contributions to the fields of genome editing and machine learning. With a focus on developing non-transgenic methods for genetic modification in plants, he has made significant strides in enhancing agricultural biotechnology.
Latest Patents
Jin Li's latest patents include "Methods For Non-Transgenic Genome Editing In Plants," which describes a method for targeted genetic modification of a plant genome without inserting exogenous genetic material. This method involves providing a plant cell with an endogenous gene to be modified, utilizing a purified Cas9 endonuclease protein along with a guide RNA for targeted recognition. The process allows for the introduction of double-stranded DNA breaks into the genome, resulting in detectable genomic modifications without the presence of exogenous Cas9 genetic material. Another notable patent is "Interactive Interfaces For Machine Learning Model Evaluations," which focuses on generating a data set for model evaluation at a machine learning service. This data set includes a prediction quality metric and allows for interactive adjustments based on client interactions.
Career Highlights
Throughout his career, Jin Li has worked with notable companies such as Thesan Pharmaceuticals, Inc. and Cellectis. His work has contributed to advancements in both pharmaceutical and agricultural technologies, showcasing his versatility as an inventor.
Collaborations
Jin Li has collaborated with esteemed colleagues, including Leo Parker Dirac and Tarun Agarwal, further enhancing his innovative projects and research endeavors.
Conclusion
Jin Li's contributions to genome editing and machine learning exemplify his commitment to innovation and technology. His work continues to influence the fields of biotechnology and artificial intelligence, paving the way for future advancements.